| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/01/16 | 15 : 49 | Dow Jones News | Roche's Cancer Injection Tecentriq SC Gets European Commission Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2024/01/10 | 22 : 45 | InvestorsHub NewsWire | GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/30 | 07 : 07 | Dow Jones News | LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/20 | 00 : 27 | Dow Jones News | Roche's Xolair Granted FDA Priority Review | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/12 | 00 : 31 | Dow Jones News | Poseida Therapeutics Shares Climb on Positive Data for Blood Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/09 | 02 : 56 | Dow Jones News | Roche Obtains Positive Data on Early-Stage Breast Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/09 | 02 : 38 | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Gets Positive Results | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/06 | 19 : 14 | Dow Jones News | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/05 | 15 : 54 | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/05 | 00 : 12 | Dow Jones News | Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/04 | 20 : 34 | Dow Jones News | Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/04 | 19 : 55 | IH Market News | Alaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and More | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/12/04 | 15 : 47 | Dow Jones News | Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/11/22 | 01 : 06 | Dow Jones News | Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/11/08 | 07 : 14 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/31 | 15 : 26 | Dow Jones News | Roche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main Goal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/27 | 14 : 40 | Dow Jones News | Roche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/24 | 04 : 41 | Dow Jones News | Trending: Roche to Buy Telavant From Roivant and Pfizer | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/23 | 17 : 16 | Dow Jones News | Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/23 | 14 : 50 | Dow Jones News | Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/19 | 18 : 55 | Dow Jones News | Roche Shares Fall on Lower Sales Due to Currency Hit | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/19 | 14 : 48 | Dow Jones News | Roche Backs Guidance After Sales Fall | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/18 | 15 : 14 | Dow Jones News | Roche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/10/18 | 14 : 54 | Dow Jones News | Roche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal Sepsis | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/09/29 | 21 : 15 | Dow Jones News | AbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple Myeloma | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/09/27 | 20 : 59 | Dow Jones News | Ionis, Roche Set New Pact Targeting Alzheimer's, Huntington's | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/09/20 | 21 : 45 | InvestorsHub NewsWire | Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/09/06 | 14 : 52 | Dow Jones News | Roche's Blood Disorder Drug Crovalimab Takes Step Toward FDA Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/09/01 | 15 : 04 | Dow Jones News | Roche Lung Cancer Drug Shows Promise in Phase 3 Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 2023/08/29 | 18 : 51 | Dow Jones News | Roche's Tecentriq Intravenous Cancer Therapy Gets UK Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |